{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:26:56Z","timestamp":1792315616129,"version":"4.4.0"},"publisher-location":"Berlin, Heidelberg","reference-count":52,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642640155","type":"print"},{"value":"9783642595370","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001]]},"DOI":"10.1007\/978-3-642-59537-0_8","type":"book-chapter","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T06:28:57Z","timestamp":1315463337000},"page":"78-92","source":"Crossref","is-referenced-by-count":28,"title":["The Clinical Utility of Multimarker RT-PCR in the Detection of Occult Metastasis in Patients with Melanoma"],"prefix":"10.1007","author":[{"given":"B.","family":"Taback","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"O\u2019Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. S. B.","family":"Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1072-7515(98)00140-9","volume":"187","author":"EC Hsueh","year":"1998","unstructured":"Hsueh EC, Gupta RK, Glass EC et al (1998) Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanoma. J AM Coll Surg 187:191\u2013197","journal-title":"J AM Coll Surg"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1998.16.3.1103","volume":"16","author":"O Eton","year":"1998","unstructured":"Eton O, Legha SS, Moon TE et al (1998) Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol 16:1103\u20131111","journal-title":"J Clin Oncol"},{"key":"8_CR3","first-page":"5054","volume":"51","author":"L Liotta","year":"1991","unstructured":"Liotta L, Stetler-Stevenson G (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51:5054\u20135059","journal-title":"Cancer Res"},{"key":"8_CR4","first-page":"6","volume":"9","author":"SA Goldblatt","year":"1965","unstructured":"Goldblatt SA, Nadel FM (1965) Cancer cells in the circulating blood: a critical review II. Acta Cytol 9:6\u201320","journal-title":"Acta Cytol"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F","volume":"80","author":"EC Woodhouse","year":"1997","unstructured":"Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer (Supp) 80:1529\u20131537","journal-title":"Cancer"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2559.1982.tb02704.x","volume":"6","author":"AP Dhillon","year":"1982","unstructured":"Dhillon AP, Rode J, Leathem A (1982) Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma. Histopathology 6:81\u201392","journal-title":"Histopathology"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/1097-0142(19940201)73:3<629::AID-CNCR2820730321>3.0.CO;2-W","volume":"73","author":"T Horikoshi","year":"1994","unstructured":"Horikoshi T, Ito S, Wakamatsu K et al (1994) Evaluation of melanin-related metabolites as markers of melanoma progression. Cancer 73:629\u2013636","journal-title":"Cancer"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0378-4347(97)00206-5","volume":"696","author":"S Letellier","year":"1997","unstructured":"Letellier S, Gamier JP, Spy J et al (1997) Determination of the L-DOPA\/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic melanoma. J Chrom B Biomed Sci Appl 696:9\u201317","journal-title":"J Chrom B Biomed Sci Appl"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00008390-199706000-00009","volume":"7","author":"M Hasegawa","year":"1997","unstructured":"Hasegawa M, Takata M, Hatta N et al (1997) Simultaneous measurement of serum 5-Scysteinyldopa, circulating intercellular adhesion molecule-1 and soluble interleukin-2 receptor levels in Japanese patients with malignant melanoma. Melanoma Res 7:243\u2013251","journal-title":"Melanoma Res"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3835(90)90073-7","volume":"52","author":"E Wibe","year":"1990","unstructured":"Wibe E, Paus E, Aamdal S (1990) Neuron specific enolase (NSE) in serum of patients with malignant melanoma. Cancer Lett 52:29\u201331","journal-title":"Cancer Lett"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00000421-199410000-00015","volume":"17","author":"AC Buzaid","year":"1994","unstructured":"Buzaid AC, Sandler AB, Hayden CL et al (1994) Neuron-specific enolase as a tumor marker in metastatic melanoma. Am J Clin Oncol 17:430\u2013431","journal-title":"Am J Clin Oncol"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/0008-8749(88)90104-9","volume":"111","author":"DSB Hoon","year":"1988","unstructured":"Hoon DSB, Irie RF, Cochran AJ (1988) Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2. Cellular Immun 111:410\u2013419","journal-title":"Cellular Immun"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000217755","volume":"13","author":"EM Schutter","year":"1992","unstructured":"Schutter EM, Visser JJ, van Kamp GJ et al (1992) The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature. Tumour Biol 13:121\u2013132","journal-title":"Tumour Biol"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02306089","volume":"3","author":"G Miliotes","year":"1996","unstructured":"Miliotes G, Lyman GH, Cruse CW et al (1996) Evaluation of new putative tumor markers for melanoma. Ann Surg Oncol 3:558\u2013563","journal-title":"Ann Surg Oncol"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/0959-8049(95)00087-Y","volume":"31","author":"HB Guo","year":"1995","unstructured":"Guo HB, Stoffel-Wagner B, Bierwirth T et al (1995) Clinical sinificance of serum S100 in metastatic malignant melanoma. Eur J Cancer 31 A:1898\u20131902","journal-title":"Eur J Cancer"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1046\/j.1365-2133.1998.02119.x","volume":"138","author":"ES Schultz","year":"1997","unstructured":"Schultz ES, Diepgen TL, Driesch P (1997) Clinical and prognostic relevance of serum S100B protein in malignant melanoma. Br J Derm 138:426\u2013430","journal-title":"Br J Derm"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000011989","volume":"56","author":"A Hauschild","year":"1999","unstructured":"Hauschild A, Engel G, Brenner W et al (1999) S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology 56:338\u2013344","journal-title":"Oncology"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/286400a0","volume":"286","author":"R Gaynor","year":"1980","unstructured":"Gaynor R, Irie R, Morton D et al (1980) S100 protein is present in cultured human malignant melanomas. Nature 286:400\u2013401","journal-title":"Nature"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(81)92142-5","volume":"1","author":"R Gaynor","year":"1981","unstructured":"Gaynor R, Herschman HR, Irie R et al (1981) S100 protein: a marker for human malignant melanomas? Lancet 1:869\u2013871","journal-title":"Lancet"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00008390-199310000-00004","volume":"3","author":"AJ Cochran","year":"1993","unstructured":"Cochran AJ, Lu HF, Li PX et al (1993) S100 protein remains a practical marker for melanocytic and other tumors. Melanoma Res 3:325\u2013330","journal-title":"Melanoma Res"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/1097-0142(19820901)50:5<912::AID-CNCR2820500519>3.0.CO;2-U","volume":"50","author":"T Nakajima","year":"1982","unstructured":"Nakajima T, Watanabe S, Sato Y et al (1982) Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 50:912\u2013918","journal-title":"Cancer"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/clinchem\/34.7.1387","volume":"34","author":"OC Fagnart","year":"1988","unstructured":"Fagnart OC, Sindic CJ, Laterre C (1988) Particle counting immunoassay of S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 34:1387\u20131391","journal-title":"Clin Chem"},{"key":"8_CR23","first-page":"601","volume":"5","author":"E Seregni","year":"1998","unstructured":"Seregni E, Massaron S, Martinetti A et al (1998) S100 protein serum levels in cutaneous malignant melanoma. Oncol Rep 5:601\u2013604","journal-title":"Oncol Rep"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/bjc.1997.232","volume":"75","author":"J Buer","year":"1997","unstructured":"Buer J, Probst M, Franzke A et al (1997) Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Cancer 75:1373\u20131376","journal-title":"Br J Cancer"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/jnci\/90.14.1099","volume":"90","author":"S Braun","year":"1998","unstructured":"Braun S, Muller M, Hepp F et al (1998) Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status (correspondence). J Natl Cancer Inst 90:1099\u20131100","journal-title":"J Natl Cancer Inst"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/bjc.1998.368","volume":"77","author":"JMG Bonfrer","year":"1998","unstructured":"Bonfrer JMG, Korse CM, Nieweg OE et al (1998) The luminescence immuoassay S-100: A sensitive test to measure circulating 5\u2013100B: its prognostic value in malignant melanoma. Br J Cancer 77:2210\u20132214","journal-title":"Br J Cancer"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/0140-6736(91)92100-G","volume":"338","author":"B Smith","year":"1991","unstructured":"Smith B, Selby P, Southgate J et al (1991) Detection of malanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. The Lancet 338:1227\u20131229","journal-title":"The Lancet"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/1523-1747.ep12371713","volume":"101","author":"P Brossart","year":"1993","unstructured":"Brossart P, Keilholz U, Willhauck M et al (1993) Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Derm 101:887\u2013889","journal-title":"J Invest Derm"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/archderm.131.4.443","volume":"131","author":"Z Battayani","year":"1995","unstructured":"Battayani Z, Grob JJ, Zerri L et al (1995) Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Derm 131:443\u2013447","journal-title":"Arch Derm"},{"key":"8_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/bjc.1995.293","volume":"72","author":"AJE Foss","year":"1995","unstructured":"Foss AJE, Guille MJ, Occleston NL et al (1995) The detection of melanoma cells in perpheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72:155\u2013159","journal-title":"Br J Cancer"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/jnci\/88.9.590","volume":"88","author":"U Kunter","year":"1996","unstructured":"Kunter U, Buer J, Probst M et al (1996) Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88:590\u2013594","journal-title":"J Natl Cancer Inst"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/oxfordjournals.annonc.a010575","volume":"7","author":"K Pittman","year":"1996","unstructured":"Pittman K, Burchill S, Smith B, et al (1996) Reverse transcriptase polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 7:297\u2013301","journal-title":"Ann Oncol"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.1996.14.7.2091","volume":"14","author":"B Mellado","year":"1996","unstructured":"Mellado B, Colomer D, Castel T et al (1996) Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis. J Clin Oncol 14:2091\u20132097","journal-title":"J Clin Oncol"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1200\/JCO.1997.15.8.2818","volume":"15","author":"R Glaser","year":"1997","unstructured":"Glaser R, Rass K, Seiter S et al (1997) Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study. J Clin Oncol 15:2818\u20132825","journal-title":"J Clin Oncol"},{"key":"8_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/1523-1747.ep12333341","volume":"108","author":"U Reinhold","year":"1997","unstructured":"Reinhold U, Ludtke-Handjery H-C, Schnautz S et al (1997) The analysis of tyrosinasespecific mRNA in blood samples of melanoma patients by reverse transcriptase polymerase chain reaction is not a useful test for metastatic tumor progression. J Invest Derm 108:166\u2013169","journal-title":"J Invest Derm"},{"key":"8_CR36","first-page":"1843","volume":"5","author":"B Mellado","year":"1999","unstructured":"Mellado B, Gutierrez L, Castel T et al (1999) Prognostic significance of the detection of circulating malignant cells by reverse transcriptase polymerase chain reaction in longterm clinically disease-free melanoma patients. Clin Cancer Res 5:1843\u20131848","journal-title":"Clin Cancer Res"},{"key":"8_CR37","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1200\/JCO.1998.16.5.1760","volume":"16","author":"BJ Curry","year":"1998","unstructured":"Curry BJ, Myers K, Hersey P (1998) Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrence from melanoma. J Clin Oncol 16:1760\u20131769","journal-title":"J Clin Oncol"},{"key":"8_CR38","first-page":"3149","volume":"57","author":"A-K Bosserhoff","year":"1997","unstructured":"Bosserhoff A-K, Kaufmann M, Kaluza B et al (1997) Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 57:3149\u20133153","journal-title":"Cancer Res"},{"key":"8_CR39","first-page":"1099","volume":"5","author":"M Muhlbauer","year":"1999","unstructured":"Muhlbauer M, Langenbach N, Stolz W et al (1999) Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transscription-polymerase chain reaction. Clin Cancer Res 5:1099\u20131105","journal-title":"Clin Cancer Res"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1200\/JCO.1995.13.8.2109","volume":"13","author":"DSB Hoon","year":"1995","unstructured":"Hoon DSB, Wang Y, Dale PS et al (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109\u20132116","journal-title":"J Clin Oncol"},{"key":"8_CR41","first-page":"1371","volume":"57","author":"T Sarantou","year":"1997","unstructured":"Sarantou T, Chi DD, Garrison DA et al (1997) Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 57:1371\u20131376","journal-title":"Cancer Res"},{"key":"8_CR42","first-page":"1414","volume":"10","author":"DSB Hoon","year":"1996","unstructured":"Hoon DSB, Garrison D, Chi DDJ et al (1996) Molecular detection of tumor-associated antigens shared by human melanomas and gliomas. EASES J 10:1414","journal-title":"EASES J"},{"key":"8_CR43","first-page":"2143","volume":"150","author":"DDJ Chi","year":"1997","unstructured":"Chi DDJ, Merchant RE, Rand R et al (1997) Molecular detection of tumorassociated antigens shared by human cuntaneous melanomas and gliomas. Am J Path 150:2143\u20132152","journal-title":"Am J Path"},{"key":"8_CR44","first-page":"411","volume":"4","author":"CT Kuo","year":"1998","unstructured":"Kuo CT, Bostick PJ, Irie RF et al (1998) Assessment of messenger RNA of \u03b2l->4-N-acetylgalactosaminyltransferase as a molecular marker for metastatic melanoma. Clin Cancer Res 4:411\u2013418","journal-title":"Clin Cancer Res"},{"key":"8_CR45","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1001\/jama.280.16.1410","volume":"280","author":"SC Shivers","year":"1998","unstructured":"Shivers SC, Wang X, Li W et al (1998) Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA 280:1410\u20131415","journal-title":"JAMA"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392\u2013399","journal-title":"Arch Surg"},{"key":"8_CR47","unstructured":"Bostick PJ, Morton DL, Turner RR et al (in press) Prognostic significance of occult metastasis detected by sentinel lymphadenectomy and RT-PCR in clinical stage I melanoma patients. J Clin Oncol"},{"key":"8_CR48","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.1997.15.7.2701","volume":"15","author":"P Zippelius","year":"1997","unstructured":"Zippelius P, Kufer P, Honold G et al (1997) Limitations of reverse-transcriptase polymerase chain reaction analysis for detection of micrometastasic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701\u20132708","journal-title":"J Clin Oncol"},{"key":"8_CR49","first-page":"241","volume":"59","author":"E Putz","year":"1999","unstructured":"Putz E, Witter K, Offner S et al (1999) Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastasis. Cancer Res 59:241\u2013248","journal-title":"Cancer Res"},{"key":"8_CR50","first-page":"419","volume":"4","author":"R Ghossein","year":"1998","unstructured":"Ghossein R, Coit D, Brennan M et al (1998) Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 4:419\u2013428","journal-title":"Clin Cancer Res"},{"key":"8_CR51","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199003013220907","volume":"322","author":"BR Zetter","year":"1990","unstructured":"Zetter BR (1990) The cellular basis of site-specific tumor metastasis. N Engl J Med 322:605\u2013612","journal-title":"N Engl J Med"},{"key":"8_CR52","first-page":"2253","volume":"60","author":"DSB Hoon","year":"2000","unstructured":"Hoon DSB, Bostick P, Kuo C et al (2000) Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 60:2253\u20132257","journal-title":"Cancer Res"}],"container-title":["Recent Results in Cancer Research","Minimal Residual Disease in Melanoma"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-59537-0_8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:43:21Z","timestamp":1606171401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-59537-0_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"ISBN":["9783642640155","9783642595370"],"references-count":52,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-59537-0_8","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]}}}